Heparin, biofilm, and catheter-related sepsis

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 1, 2008, Pages 80-

  Diskin, Charles J ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; IRON; SERUM ALBUMIN;

BACTERIUM ADHERENCE; BIOFILM; CANDIDA ALBICANS; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; ENTEROCOCCUS FAECALIS; HEMODIALYSIS; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RISK FACTOR; SEPSIS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS LUGDUNENSIS; STREPTOBACILLUS MONILIFORMIS; TORULOPSIS GLABRATA; YERSINIA ENTEROCOLITICA;

BACTERIAL PHYSIOLOGY; BIOFILMS; CATHETERIZATION; CROSS INFECTION; EQUIPMENT AND SUPPLIES; HEPARIN; HUMANS; SEPSIS;

EID: 42049095906     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.12.008     Document Type: Letter

References (4)

1. Diskin C.J., Stokes T.J., Dansby L.M., Radcliff L., and Carter T.B. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors. Nephron Clin. Pract. 107 (2007) c128-c132
2. Frank K.L., and Patel R. Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci. Diagn. Microbiol. Infect. Dis. 60 (2008) 9-16
3. Sengoelge G., Sunder-Plassmann G., and Horl W.H. Potential risk for infection and atherosclerosis due to iron therapy. J. Ren. Nutr. 15 (2005) 105-110
4. Shanks R.M., Donegan N.P., Graber M.L., Buckingham S.E., Zegans M.E., Cheung A.L., and O'Toole G.A. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 73 (2005) 4596-4606